200 related articles for article (PubMed ID: 10730343)
21. Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009.
Al Shaer L; AbdulRahman M; John TJ; AlHashimi A
Transfusion; 2012 Nov; 52(11):2300-9. PubMed ID: 22691239
[TBL] [Abstract][Full Text] [Related]
22. Yield and future issues of nucleic acid testing.
Roth WK; Seifried E
Transfus Clin Biol; 2001 Jun; 8(3):282-4. PubMed ID: 11499978
[TBL] [Abstract][Full Text] [Related]
23. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
Busch MP
Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546
[TBL] [Abstract][Full Text] [Related]
24. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ;
Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
[TBL] [Abstract][Full Text] [Related]
25. Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States.
Zou S; Dodd RY; Stramer SL; Strong DM;
N Engl J Med; 2004 Aug; 351(8):751-9. PubMed ID: 15317888
[TBL] [Abstract][Full Text] [Related]
26. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of human immunodeficiency virus RNA and antibody in first-time, lapsed, and repeat blood donations across five international regions and relative efficacy of alternative screening scenarios.
Bruhn R; Lelie N; Custer B; Busch M; Kleinman S;
Transfusion; 2013 Oct; 53(10 Pt 2):2399-412. PubMed ID: 23782054
[TBL] [Abstract][Full Text] [Related]
28. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population.
Dodd RY; Notari EP; Stramer SL
Transfusion; 2002 Aug; 42(8):975-9. PubMed ID: 12385406
[TBL] [Abstract][Full Text] [Related]
29. Blood donors screening for blood born viruses in Poland.
Grabarczyk P; Kopacz A; Sulkowska E; Kubicka-Russel D; Mikulska M; Brojer E; Łętowska M
Przegl Epidemiol; 2015; 69(3):473-7, 591-5. PubMed ID: 26519842
[TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness of additional blood screening tests in the Netherlands.
Borkent-Raven BA; Janssen MP; van der Poel CL; Bonsel GJ; van Hout BA
Transfusion; 2012 Mar; 52(3):478-88. PubMed ID: 21880046
[TBL] [Abstract][Full Text] [Related]
31. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services.
O'Brien SF; Yi QL; Fan W; Scalia V; Kleinman SH; Vamvakas EC
Transfusion; 2007 Feb; 47(2):316-25. PubMed ID: 17302779
[TBL] [Abstract][Full Text] [Related]
32. Emerging viruses and transfusion.
Allain JP
Transfus Clin Biol; 2001 Jun; 8(3):220-1. PubMed ID: 11499963
[TBL] [Abstract][Full Text] [Related]
33. Two HBV DNA+/HBsAg- blood donors identified by HBV NAT in Shenzhen, China.
Shang G; Yan Y; Yang B; Shao C; Wang F; Li Q; Seed CR
Transfus Apher Sci; 2009 Aug; 41(1):3-7. PubMed ID: 19487161
[TBL] [Abstract][Full Text] [Related]
34. High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan.
Mine H; Emura H; Miyamoto M; Tomono T; Minegishi K; Murokawa H; Yamanaka R; Yoshikawa A; Nishioka K;
J Virol Methods; 2003 Sep; 112(1-2):145-51. PubMed ID: 12951223
[TBL] [Abstract][Full Text] [Related]
35. [Residual risks of viral transmission by transfusions and projected yields of additional screening tests. Retrovirus Epidemiology Donors Study (REDS)].
Busch MP
Transfus Clin Biol; 1996; 3(1):7-11. PubMed ID: 8640316
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of transfusion-associated viral infections and syphilis among blood donors in Muhimbili Medical Centre, Dar es Salaam, Tanzania.
Matee MI; Lyamuya EF; Mbena EC; Magessa PM; Sufi J; Marwa GJ; Mwasulama OJ; Mbwana J
East Afr Med J; 1999 Mar; 76(3):167-71. PubMed ID: 10442119
[TBL] [Abstract][Full Text] [Related]
37. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing.
Stramer SL; Glynn SA; Kleinman SH; Strong DM; Caglioti S; Wright DJ; Dodd RY; Busch MP;
N Engl J Med; 2004 Aug; 351(8):760-8. PubMed ID: 15317889
[TBL] [Abstract][Full Text] [Related]
38. Human immunodeficiency virus-1 and hepatitis C virus RNA among South African blood donors: estimation of residual transfusion risk and yield of nucleic acid testing.
Fang CT; Field SP; Busch MP; Heyns Adu P
Vox Sang; 2003 Jul; 85(1):9-19. PubMed ID: 12823725
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic accuracy of blood centers in the screening of blood donors for viral markers.
Dogbe EE; Arthur F
Pan Afr Med J; 2015; 20():119. PubMed ID: 26090067
[TBL] [Abstract][Full Text] [Related]
40. [Relevance of safety measures to avoid HTLV transmission by transfusion in 2014].
Laperche S; Pillonel J
Transfus Clin Biol; 2014 Nov; 21(4-5):167-72. PubMed ID: 25267203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
